| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20037777 | HPV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS20014401 | HPV | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS44034463 | HTLV-1 | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
| TVIS44036664 | HTLV-1 | ENSG00000101958.14 | protein_coding | GLRA2 | No | No | 2742 | P23416 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GLRA2 |
|---|---|
| DrugBank ID | DB01956 |
| Drug Name | Taurine |
| Target ID | BE0000745 |
| UniProt ID | P23416 |
| Regulation Type | agonist |
| PubMed IDs | |
| Citations | |
| Groups | Approved; Nutraceutical |
| Direct Classification | Organosulfonic acids |
| SMILES | NCCS(O)(=O)=O |
| Pathways | Congenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX) |
| PharmGKB | PA451590 |
| ChEMBL | CHEMBL239243 |
